These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10928962)

  • 1. A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13 - 52) to modulate microvascular but not thermal hyperalgesia responses.
    Chu DQ; Choy M; Foster P; Cao T; Brain SD
    Br J Pharmacol; 2000 Aug; 130(7):1589-96. PubMed ID: 10928962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of human adrenomedullin 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster.
    Hall JM; Siney L; Lippton H; Hyman A; Kang-Chang J; Brain SD
    Br J Pharmacol; 1995 Feb; 114(3):592-7. PubMed ID: 7735685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calcitonin gene-related peptide (CGRP) antagonist CGRP(8-37) blocks vasodilatation in inflamed rat skin: involvement of adrenomedullin in addition to CGRP.
    Chu DQ; Legon S; Smith DM; Costa SK; Cuttitta F; Brain SD
    Neurosci Lett; 2001 Sep; 310(2-3):169-72. PubMed ID: 11585594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of adrenomedullin, an adrenomedullin analog, and CGRP in the pulmonary vascular bed of the cat and rat.
    Nossaman BD; Feng CJ; Cheng DY; Dewitt BJ; Coy DH; Murphy WA; Kadowitz PJ
    Life Sci; 1995; 56(3):PL63-6. PubMed ID: 7823766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve.
    Escott KJ; Brain SD
    Br J Pharmacol; 1993 Oct; 110(2):772-6. PubMed ID: 8242250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: a study using in vivo and in vitro assays in the mouse.
    Tam C; Brain SD
    J Mol Neurosci; 2004; 22(1-2):117-24. PubMed ID: 14742916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin.
    Hughes SR; Brain SD
    Br J Pharmacol; 1991 Nov; 104(3):738-42. PubMed ID: 1797334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the microvascular effects of adrenomedullin and related peptides.
    Chu DQ; Smith DM; Brain SD
    Peptides; 2001 Nov; 22(11):1881-6. PubMed ID: 11754976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modulation of inflammatory oedema by calcitonin gene-related peptide.
    Newbold P; Brain SD
    Br J Pharmacol; 1993 Mar; 108(3):705-10. PubMed ID: 7682134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw.
    Bileviciute I; Stenfors C; Theodorsson E; Lundeberg T
    Br J Pharmacol; 1998 Nov; 125(6):1304-12. PubMed ID: 9863661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat.
    Champion HC; Santiago JA; Murphy WA; Coy DH; Kadowitz PJ
    Am J Physiol; 1997 Jan; 272(1 Pt 2):R234-42. PubMed ID: 9039014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the feline erection model.
    Champion HC; Wang R; Santiago JA; Murphy WA; Coy DH; Kadowitz PJ; Hellstrom WJ
    J Androl; 1997; 18(5):513-21. PubMed ID: 9349749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of adrenomedullin and calcitonin gene-related peptide receptors in vascular smooth muscle cells--effects of receptor activity-modifying protein.
    Qi YF; Xue L; Chai SB; Shi YR; Pang YZ; Tang CS
    Sheng Li Xue Bao; 2001 Oct; 53(5):396-400. PubMed ID: 11833426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle.
    Yousufzai SY; Ali N; Abdel-Latif AA
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3245-53. PubMed ID: 10586949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide.
    Buckley TL; Brain SD; Collins PD; Williams TJ
    J Immunol; 1991 May; 146(10):3424-30. PubMed ID: 1673985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of adrenomedullin (ADM) and its binding sites in the rat uterus: increased number of binding sites and ADM messenger ribonucleic acid in 20-day pregnant rats compared with nonpregnant rats.
    Upton PD; Austin C; Taylor GM; Nandha KA; Clark AJ; Ghatei MA; Bloom SR; Smith DM
    Endocrinology; 1997 Jun; 138(6):2508-14. PubMed ID: 9165042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
    Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of CGRP (8-37), but not adrenomedullin (22-52), on the haemodynamic responses to lipopolysaccharide in conscious rats.
    Gardiner SM; March JE; Kemp PA; Bennett T
    Br J Pharmacol; 1999 Aug; 127(7):1611-8. PubMed ID: 10455317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation.
    Buckley TL; Brain SD; Rampart M; Williams TJ
    Br J Pharmacol; 1991 Jun; 103(2):1515-9. PubMed ID: 1884106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
    Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
    Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.